Evidence map›Paper›PMID 27879027›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Arenophile-Mediated Dearomative Reduction.

Mikiko Okumura, Stephanie M Nakamata Huynh, Jola Pospech, David Sarlah

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Energy-Transfer Catalysis Enables the Birch-Type Reduction of 2-Pyridones.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Copper-Catalyzed Dearomative 1,2-Hydroamination.Angewandte Chemie (International ed. in English) · 2024
    Article
  7. Review
  8. Interrupted SJACS Au · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Visible-Light-Induced Dearomatizations.European journal of organic chemistry · 2020
    Article
  16. Review
  17. Article
  18. Palladium-Catalyzed Dearomative syn-1,4-Diamination.Journal of the American Chemical Society · 2019
    Article
  19. Article
  20. Palladium-Catalyzed Dearomative syn-1,4-Carboamination.Journal of the American Chemical Society · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mikiko OkumuraRoger Adams Laboratory, Department of Chemistry, University of Illinois, Illinois, 61801, USA.
Stephanie M Nakamata HuynhRoger Adams Laboratory, Department of Chemistry, University of Illinois, Illinois, 61801, USA.
Jola PospechRoger Adams Laboratory, Department of Chemistry, University of Illinois, Illinois, 61801, USA.
David SarlahRoger Adams Laboratory, Department of Chemistry, University of Illinois, Illinois, 61801, USA.ORCID 0000-0002-8736-8953

Funding

Dearomative Functionalization with ArenophilesR01GM122891 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SARLAH, DAVID · 2017 to 2025
$3.1M
NIGMS NIH HHS R01 GM122891
6 · The paper itself

Abstract

A dearomative reduction of simple arenes has been developed which employs a visible-light-mediated cycloaddition of arenes with an N-N-arenophile and in situ diimide reduction. Subsequent cycloreversion or fragmentation of the arenophile moiety affords 1,3-cyclohexadienes or 1,4-diaminocyclohex-2-enes, compounds that are not synthetically accessible using existing dearomatization reactions. Importantly, this strategy also provides numerous opportunities for further derivatization as well as site-selective functionalization of polynuclear arenes.

Indexed as

arenesarenophilesdearomatizationfunctionalizationphotochemistry

Identifiers

PMID27879027
PMCPMC6043355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.